Relationship of dementia screening tests with biomarkers of Alzheimers disease

Author： Galvin James E.   Fagan Anne M.   Holtzman David M.   Mintun Mark A.   Morris John C.  

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.133, Iss.11, 2010-11, pp. : 3290-3300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters

By  

Current Alzheimer Research, Vol. 7, Iss. 1, 2010-02 ,pp. : 56-66

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite

Vascular Dementia: Atherosclerosis, Cognition and Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 8, Iss. 4, 2011-06 ,pp. : 341-344

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of Neuropsychiatric Symptoms in Alzheimer's Disease and Vascular Dementia

By  

Current Alzheimer Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite

Impaired Renal Function and Biomarkers of Vascular Disease in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 3, 2014-03 ,pp. : 253-258

Bentham Science Publishers

Access to resources Recommend Favorite